Sensing the Invisible

PressureSafe, an innovative non-invasive medical device using infrared optical spectroscopy and AI analysis, is designed for effective detection of early-stage pressure injuries for all skin tones

* PressureSafe is not yet available for commercial use. Expected US launch: H2/2023.

$26.8B pressure injury problem in US requires a solution

2.5 MILLION patients per year develop pressure injuries
60,000 patients die every year as a direct result of pressure injuries.
Patients with hospital acquired pressure injuries (HAPI) have a median excess length of stay of 4.31 days.
Patients with HAPI have higher 30-day readmission rates (22.6% vs. 17.6%)
HAPI rates are increasing. All other hospital acquired conditions are decreasing (AHRQ, 2019).
17,000 directly related lawsuites to pressure injury.

Introducing PressureSafe

IR-Med is developing a unique technology platform for easy-to-use, non-invasive, personalized medical devices for real-time detection and monitoring of tissue and blood biomarkers

* PressureSafe is not yet available for commercial use. Expected US launch: H2/2023.

effective for all skin tones
Harmless INFRAREd light
Disposable
tip
Real-time measurement
EMR/EHR connectivity
Ergonomic Design
Tactile grip
SCANS BENEATH THE skin surface
Multiple Biomarkers
Personalized medical device
Camera for documentation
Cloud-based
AI inside